As previously reported, Wells Fargo analyst Stan Berenshteyn upgraded Doximity (DOCS) to Equal Weight from Underweight with a price target of $41, up from $19, after a Q2 beat. Doximity’s ability to benefit from upsells seems stronger than suggested by survey and channel checks, according to the firm, which also thinks fiscal Q3 could see persistence of the tailwinds seen in Q2, making it “difficult to build a case for underperformance.”
Don't Miss out on Research Tools:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOCS: